Caitlin Vink

120 Chapter 6 Table 2. Baseline characteristics ANOCA-patients (continued) Total Women Men p-value Total number of patients n = 28 n = 22 n = 6 Beta-blocker, % 7 (25.9) 5 (23.8) 2 (33.3) 0.633 Calcium antagonist, % 19 (70.4) 15 (71.4) 4 (66.7) 1.000 Nitrates, % 19 (70.4) 14 (66.7) 5 (83.3) 0.633 Long acting nitrates, % 12 (63.2) 8 (57.1) 4 (80.0) 0.603 Short acting nitrates, % 16 (84.2) 12 (85.7) 4 (80.0) 1.000 Statins, % 16 (59.3) 13 (61.9) 3 (50.0) 0.662 Non-Insulin agens for DM, % 3 (10.7) 3 (13.6) 0 (0) 1.000 CFT result Vasospasm Epicardial spasm, % 3 (10.7) 1 (4.5) 2 (33.3) 0.530 Microvascular spasm, % 11 (39.3) 11 (50.0) 0 (0.0) 0.055 Inconclusive, % 9 (32.1) 8 (36,4) 1 (16,7) 0.630 Coronary Microvascular Dysfunction CFR 2.87 ±0.57 2.80 ±0.56 3.09 ±0.57 0.143 HMR, mmHg/cm/s, [IQR] 1.70 [1.30-2.07] 1.78 [1.30-2.07] 1.41 [1.32-3.11] 0.586 Reduced CFR (≤2.5), % 7 (25) 6 (27.3) 1 (16.7) 1.000 Increased HMR (>2.5), % 2 (9.5) 1 (5.9) 1 (25.0) 0.352 Negative CFT, % 3 (10.7) 2 (9.1) 1 (16.7) 0.530 Microvascular Angina, % 14 (50.0) 11 (50.0) 3 (50.0) 1.000 Heart rate Baseline heartrate (BPM), % 77.1 ±12.3 76.0 ±12.0 80.8 ±13.9 0.407 Max heartrate in stress, BPM, % 132.2 ±23.3 131.4 ±21.9 135.3 ±29.8 0.718 Data are presented as mean ± SD Abbreviations: yrs: years; BMI: Body Mass Index; NYHA: New York Heart Association; DM: Diabetes Mellitus; CFR: Coronary Flow Reserve; HMR: Hyperemic Microvascular Resistance index; IQR: interquartile range; BPM: Beats Per Minute

RkJQdWJsaXNoZXIy MTk4NDMw